+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report by Drug Type, Drug Class, Route of Administration, Application, Distribution Channel, Region, and Growth Forecasts, 2026-2033- Product Image
Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report by Drug Type, Drug Class, Route of Administration, Application, Distribution Channel, Region, and Growth Forecasts, 2026-2033- Product Image
New

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report by Drug Type, Drug Class, Route of Administration, Application, Distribution Channel, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 140 Pages
  • March 2026
  • Region: Global
  • Grand View Research
  • ID: 4538793
REQUEST CUSTOMIZATION
Description Jump to:
The global gastrointestinal therapeutics market size was estimated at USD 42.75 billion in 2025 and is projected to reach USD 51.45 billion by 2033, growing at a CAGR of 2.2% from 2026 to 2033. The industry is expanding due to the rising incidence of digestive disorders across both developed and emerging regions.

The increasing prevalence of gastroesophageal reflux disease, irritable bowel syndrome, inflammatory bowel disease, and peptic ulcer disorders is strengthening the demand for long-term pharmacological management. Rapid urbanization, processed food consumption, irregular eating patterns, and elevated stress exposure are contributing to persistent gastrointestinal complications. A larger diagnosed patient population is seeking continuous symptom relief and disease control therapies. Higher consultation rates in primary and specialty care settings are further supporting prescription volumes.

Growing awareness regarding early symptom recognition is encouraging timely treatment initiation. For instance, in January 2026, Current Gastroenterology Reports, a Springer publication, reviewed acute severe ulcerative colitis and reported that intravenous corticosteroid therapy, used for about 70 years remained associated with colectomy rates of 25% to 30%, while severe flares occurred in 25% to 50% of patients during their disease course and 20% presented with a severe flare initially. The analysis further noted cumulative colectomy rates rising from 19.9% after the first admission to 38.6% after four admissions, and first year mortality of 40% to 75% in the pre steroid era, which declined to below 1% in the modern era, yet increased to about 5% in older or refractory cases, underscoring significant unmet clinical need.

Advancements in pharmaceutical research and product innovation are significantly contributing to market growth. Development of biologics, targeted small molecules, and improved acid suppression therapies is enhancing clinical outcomes for chronic gastrointestinal conditions. Novel drug delivery systems are improving absorption profiles and reducing adverse effects, strengthening patient adherence. Precision based treatment strategies are supporting individualized therapeutic regimens in inflammatory bowel disease and related disorders.

Global Gastrointestinal Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global gastrointestinal therapeutics market report based on drug type, drug class, route of administration, application, distribution channel, and region:

Drug Type Outlook (Revenue, USD Million, 2021-2033)

  • Branded
  • Generics

Drug Class Outlook (Revenue, USD Million, 2021-2033)

  • Aminosalicylates
  • Digestive Enzymes
  • Proton Pump Inhibitors
  • Laxatives
  • Anti-emetics
  • H2 Antagonists
  • Anti-diarrheals
  • Biologics/ Biosimilar
  • Others

Route of Administration Outlook (Revenue, USD Million, 2021-2033)

  • Oral
  • Injectables
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Crohn's disease
  • Ulcerative colitis
  • GERD
  • IBS
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Type
1.2.2. Drug Class
1.2.3. Route of Administration
1.2.4. Application
1.2.5. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Gastrointestinal Therapeutics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Gastrointestinal Therapeutics Market: Drug Type Business Analysis
4.1. Drug Type Market Share, 2025 & 2033
4.2. Drug Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
4.4. Branded
4.4.1. Branded Market, 2021-2033 (USD Million)
4.5. Generics
4.5.1. Generics Market, 2021-2033 (USD Million)
Chapter 5. Gastrointestinal Therapeutics Market: Drug Class Business Analysis
5.1. Drug Class Market Share, 2025 & 2033
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug class, 2021 to 2033 (USD Million)
5.4. Aminosalicylates
5.4.1. Aminosalicylates Market, 2021-2033 (USD Million)
5.5. Digestive Enzymes
5.5.1. Digestive Enzymes Market, 2021-2033 (USD Million)
5.6. Proton Pump Inhibitors
5.6.1. Proton Pump Inhibitors Market, 2021-2033 (USD Million)
5.7. Laxatives
5.7.1. Laxatives Market, 2021-2033 (USD Million)
5.8. Anti-emetics
5.8.1. Anti-emetics Market, 2021-2033 (USD Million)
5.9. H2 Antagonists
5.9.1. H2 Antagonists Market, 2021-2033 (USD Million)
5.10. Anti-diarrheals
5.10.1. Anti-diarrheals Market, 2021-2033 (USD Million)
5.11. Biologics/Biosimilar
5.11.1. Biologics/Biosimilar Market, 2021-2033 (USD Million)
5.12. Others
5.12.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Gastrointestinal Therapeutics Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2025 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of administration, 2021 to 2033 (USD Million)
6.4. Oral
6.4.1. Oral Market, 2021-2033 (USD Million)
6.5. Injectables
6.5.1. Injectables Market, 2021-2033 (USD Million)
6.6. Others
6.6.1. Others Market, 2021-2033 (USD Million)
Chapter 7. Gastrointestinal Therapeutics Market: Application Business Analysis
7.1. Application Market Share, 2025 & 2033
7.2. Application Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Crohn's disease
7.4.1. Crohn's disease Market, 2021-2033 (USD Million)
7.5. Ulcerative colitis
7.5.1. Ulcerative colitis Market, 2021-2033 (USD Million)
7.6. GERD
7.6.1. GERD Market, 2021-2033 (USD Million)
7.7. IBS
7.7.1. IBS Market, 2021-2033 (USD Million)
7.8. Others
7.8.1. Others Market, 2021-2033 (USD Million)
Chapter 8. Gastrointestinal Therapeutics Market: Distribution Channel Business Analysis
8.1. Distribution Channel Market Share, 2025 & 2033
8.2. Distribution Channel Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
8.4. Hospital Pharmacies
8.4.1. Hospital Pharmacies Market, 2021-2033 (USD Million)
8.5. Retail Pharmacies
8.5.1. Retail Pharmacies Market, 2021-2033 (USD Million)
8.6. Online Pharmacies
8.6.1. Online Pharmacies Market, 2021-2033 (USD Million)
Chapter 9. Gastrointestinal Therapeutics Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
9.4.1. North America Gastrointestinal Therapeutics Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
9.4.2. U.S.
9.4.3. Canada
9.4.4. Mexico
9.5. Europe
9.5.1. Europe Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.2. UK
9.5.3. Germany
9.5.4. France
9.5.5. Italy
9.5.6. Spain
9.5.7. Denmark
9.5.8. Sweden
9.5.9. Norway
9.6. Asia-Pacific
9.6.1. Asia-Pacific Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6.2. Japan
9.6.3. China
9.6.4. India
9.6.5. Australia
9.6.6. South Korea
9.6.7. Thailand
9.7. Latin America
9.7.1. Latin America Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7.2. Brazil
9.7.3. Argentina
9.8. Middle East and Africa
9.8.1. Middle East and Africa Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.8.2. South Africa
9.8.3. Saudi Arabia
9.8.4. UAE
9.8.5. Kuwait
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. AbbVie Inc.
10.5.2. AstraZeneca
10.5.3. Salix Pharmaceuticals
10.5.4. Takeda Pharmaceutical Company Limited
10.5.5. Pfizer Inc.
10.5.6. Bayer AG
10.5.7. Abbott
10.5.8. Janssen Pharmaceuticals NV
10.5.9. Sun Pharmaceutical Industries Ltd.
10.5.10. Cipla Inc.
10.5.11. Gilead Sciences, Inc.
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global gastrointestinal therapeutics market, by region, 2021-2033 (USD Million)
Table 4 Global gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 5 Global gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 6 Global gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 7 Global gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 8 Global gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 9 North America gastrointestinal therapeutics market, by country, 2021-2033 (USD Million)
Table 10 North America gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 11 North America gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 12 North America gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 13 North America gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 14 North America gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 15 U.S. gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 16 U.S. gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 17 U.S. gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 18 U.S. gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 19 U.S. gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 20 Canada gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 21 Canada gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 22 Canada gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 23 Canada gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 24 Canada gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 25 Mexico gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 26 Mexico gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 27 Mexico gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 28 Mexico gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 29 Mexico gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 30 Europe gastrointestinal therapeutics market, by country, 2021-2033 (USD Million)
Table 31 Europe gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 32 Europe gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 33 Europe gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 34 Europe gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 35 Europe gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 36 UK gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 37 UK gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 38 UK gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 39 UK gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 40 UK gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 41 Germany gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 42 Germany gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 43 Germany gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 44 Germany gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 45 Germany gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 46 France gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 47 France gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 48 France gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 49 France gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 50 France gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 51 Italy gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 52 Italy gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 53 Italy gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 54 Italy gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 55 Italy gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 56 Spain gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 57 Spain gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 58 Spain gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 59 Spain gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 60 Spain gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 61 Norway gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 62 Norway gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 63 Norway gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 64 Norway gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 65 Norway gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 66 Denmark gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 67 Denmark gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 68 Denmark gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 69 Global gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 70 Global gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 71 Sweden gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 72 Sweden gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 73 Sweden gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 74 Sweden gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 75 Sweden gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 76 Asia-Pacific gastrointestinal therapeutics market, by country, 2021-2033 (USD Million)
Table 77 Asia-Pacific gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 78 Asia-Pacific gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 79 Asia-Pacific gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 80 Asia-Pacific gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 81 Asia-Pacific gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 82 Japan gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 83 Japan gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 84 Japan gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 85 Japan gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 86 Japan gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 87 China gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 88 China gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 89 China gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 90 China gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 91 China gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 92 India gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 93 India gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 94 India gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 95 India gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 96 India gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 97 Australia gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 98 Australia gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 99 Australia gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 100 Australia gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 101 Australia gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 102 South Korea gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 103 South Korea gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 104 South Korea gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 105 South Korea gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 106 South Korea gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 107 Thailand gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 108 Thailand gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 109 Thailand gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 110 Thailand gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 111 Thailand gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 112 Latin America gastrointestinal therapeutics market, by country, 2021-2033 (USD Million)
Table 113 Latin America gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 114 Latin America gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 115 Latin America gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 116 Latin America gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 117 Latin America gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 118 Brazil gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 119 Brazil gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 120 Brazil gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 121 Brazil gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 122 Brazil gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 123 Argentina gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 124 Argentina gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 125 Argentina gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 126 Argentina gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 127 Argentina gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 128 Middle East & Africa gastrointestinal therapeutics market, by country, 2021-2033 (USD Million)
Table 129 Middle East & Africa gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 130 Middle East & Africa gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 131 Middle East & Africa gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 132 Middle East & Africa gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 133 Middle East & Africa gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 134 South Africa gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 135 South Africa gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 136 South Africa gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 137 South Africa gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 138 South Africa gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 139 Saudi Arabia gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 140 Saudi Arabia gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 141 Saudi Arabia gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 142 Saudi Arabia gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 143 Saudi Arabia gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 144 UAE gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 145 UAE gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 146 UAE gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 147 UAE gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 148 UAE gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
Table 149 Kuwait gastrointestinal therapeutics market, by drug type, 2021-2033 (USD Million)
Table 150 Kuwait gastrointestinal therapeutics market, by drug class, 2021-2033 (USD Million)
Table 151 Kuwait gastrointestinal therapeutics market, by route of administration, 2021-2033 (USD Million)
Table 152 Kuwait gastrointestinal therapeutics market, by application, 2021-2033 (USD Million)
Table 153 Kuwait gastrointestinal therapeutics market, by distribution channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Gastrointestinal Therapeutics Market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Competitive landscape
Figure 10 Gastrointestinal Therapeutics Market dynamics
Figure 11 Gastrointestinal Therapeutics Market: Porter’s five forces analysis
Figure 12 Gastrointestinal Therapeutics Market: PESTLE analysis
Figure 13 Drug type market, 2021-2033 (USD Million)
Figure 14 Branded market, 2021-2033 (USD Million)
Figure 15 Generics market, 2021-2033 (USD Million)
Figure 16 Drug class market, 2021-2033 (USD Million)
Figure 17 Aminosalicylates market, 2021-2033 (USD Million)
Figure 18 Digestive Enzymes market, 2021-2033 (USD Million)
Figure 19 Proton Pump Inhibitors market, 2021-2033 (USD Million)
Figure 20 Laxatives market, 2021-2033 (USD Million)
Figure 21 Anti-emetics market, 2021-2033 (USD Million)
Figure 22 H2 Antagonists market, 2021-2033 (USD Million)
Figure 23 Anti-diarrheals market, 2021-2033 (USD Million)
Figure 24 Biologics/Biosimilar market, 2021-2033 (USD Million)
Figure 25 Others market, 2021-2033 (USD Million)
Figure 26 Route of Administration market, 2021-2033 (USD Million)
Figure 27 Oral market, 2021-2033 (USD Million)
Figure 28 Injectables market, 2021-2033 (USD Million)
Figure 29 Others market, 2021-2033 (USD Million)
Figure 30 Application market, 2021-2033 (USD Million)
Figure 31 Crohn's disease market, 2021-2033 (USD Million)
Figure 32 Ulcerative colitis market, 2021-2033 (USD Million)
Figure 33 GERD market, 2021-2033 (USD Million)
Figure 34 IBS market, 2021-2033 (USD Million)
Figure 35 Others market, 2021-2033 (USD Million)
Figure 36 Distribution Channel market, 2021-2033 (USD Million)
Figure 37 Hospital Pharmacies market, 2021-2033 (USD Million)
Figure 38 Retail Pharmacies market, 2021-2033 (USD Million)
Figure 39 Online Pharmacies market, 2021-2033 (USD Million)
Figure 40 Gastrointestinal Therapeutics Market revenue, by region
Figure 41 Regional marketplace: Key takeaways
Figure 42 North America Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 43 U.S. country dynamics
Figure 44 U.S. Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 45 Canada country dynamics
Figure 46 Canada Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 47 Mexico country dynamics
Figure 48 Mexico Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 49 Europe Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 50 UK country dynamics
Figure 51 UK Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 52 Germany country dynamics
Figure 53 Germany Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 54 France country dynamics
Figure 55 France Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 56 Italy country dynamics
Figure 57 Italy Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 58 Spain country dynamics
Figure 59 Spain Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 60 Norway country dynamics
Figure 61 Norway Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 62 Sweden country dynamics
Figure 63 Sweden Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 64 Denmark country dynamics
Figure 65 Denmark Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 66 Asia-Pacific Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 67 Japan country dynamics
Figure 68 Japan Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 69 China country dynamics
Figure 70 China Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 71 India country dynamics
Figure 72 India Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 73 Australia country dynamics
Figure 74 Australia Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 75 South Korea country dynamics
Figure 76 South Korea Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 77 Thailand country dynamics
Figure 78 Thailand Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 79 Latin America Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 80 Brazil country dynamics
Figure 81 Brazil Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 82 Argentina country dynamics
Figure 83 Argentina Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 84 MEA Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 85 South Africa country dynamics
Figure 86 South Africa Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 87 Saudi Arabia country dynamics
Figure 88 Saudi Arabia Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 89 UAE country dynamics
Figure 90 UAE Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 91 Kuwait country dynamics
Figure 92 Kuwait Gastrointestinal Therapeutics Market, 2021-2033 (USD Million)
Figure 93 Company categorization
Figure 94 Company market position analysis
Figure 95 Strategic framework

Companies Mentioned

  • AbbVie Inc.
  • AstraZeneca
  • Salix Pharmaceuticals
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Bayer AG
  • Abbott
  • Janssen Pharmaceuticals NV
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Gilead Sciences, Inc.

Table Information

Report AttributeDetails
No. of Pages140
PublishedMarch 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 42.75 Billion
Forecasted Market Value ( USD ) by 2033 $ 51.45 Billion
Compound Annual Growth Rate2.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gastrointestinal Drugs Market - A Global and Regional Analysis: Focus on Application, Route of Administration, Distribution Channel, Drug Class, and Country-Level Analysis - Analysis and Forecast, 2025-2035 - Product Image

Gastrointestinal Drugs Market - A Global and Regional Analysis: Focus on Application, Route of Administration, Distribution Channel, Drug Class, and Country-Level Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • 497 Pages
  • Global
From
Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033 - Product Image

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033

  • Report
  • 133 Pages
  • Global
From
Acute Pancreatitis Market Forecast to 2033 - Product Image

Acute Pancreatitis Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Gastrointestinal Devices Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Gastrointestinal Devices Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.